The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Completion of adjuvant trastuzumab for older patients with early-stage breast cancer (BC).
Rachel A. Freedman
No relevant relationships to disclose
Ines Maria Vaz Duarte Luis
No relevant relationships to disclose
Nancy Lin
No relevant relationships to disclose
Joyce Lii
No relevant relationships to disclose
Eric P. Winer
No relevant relationships to disclose
Nancy Lynn Keating
No relevant relationships to disclose